5-TRANS U-46619
- CAS NO.:330796-58-2
- Empirical Formula: C21H34O4
- Molecular Weight: 350.49
- MDL number: MFCD00216069
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-06-08 09:02:17
What is 5-TRANS U-46619?
The Uses of 5-TRANS U-46619
U-46619 is a TP receptor agonist that exhibits properties similar to Thromboxane A2, inducing platelet aggregation and vascular smooth muscle contraction. 5-trans U-46619 is a minor impurity (2-5%) which is variably present in most commercial preparations of U-46619. The biological activity of 5-trans U-46619 has rarely been tested separately from U-46619 itself. In the only case published to date, 5-trans U-46619 was found to be a about half as potent an inhibitor of Prostaglandin E synthase as the 5-cis version of U-46619.[Cayman Chemical]
What are the applications of Application
5-trans U-46619 is a TXA2R (Prostaglandin H2/thromboxane A2 receptor) agonist
Biological Activity
5-trans u-46619 is a minor impurity (2-5%) which variably exists in most commercial preparations of u-46619 [1]. u-46619 is a selective thromboxane a2 agonist involved in inducing platelet aggregation and vascular smooth muscle contraction [2].the biological activity of 5-trans u-46619 has been rarely tested separately from u-46619 itself. in the only case published to date, 5-trans u-46619 was found to be a about half as potent an inhibitor of prostaglandin e synthase as the 5-cis version of u-46619 [1]. thromboxane a2 (txa2) has been involved in the pathogenesis of airway hyperresponsiveness. txa2 is a type of thromboxane produced by activated platelets and shows prothrombotic properties. thromboxane a2 has also been known as a vasoconstrictor and is especially important during tissue injury and inflammation [3].
References
[1] quraishi o, mancini j a, riendeau d. inhibition of inducible prostaglandin e 2 synthase by 15-deoxy-δ 12, 14-prostaglandin j 2 and polyunsaturated fatty acids[j]. biochemical pharmacology, 2002, 63(6): 1183-1189.
[2] coleman, r. a.,humphrey, p.p.a.,kennedy, i., et al. comparison of the actions of u-46619, a prostaglandin h2-analogue, with those of prostaglandin h2 and thromboxane a2 on some isolated smooth muscle preparations. british journal of pharmacology 73, 773-778 (1981).
[3] svensson j, strandberg k, tuvemo t, et al. thromboxane a2: effects of airway and vascular smooth muscle[j]. prostaglandins, 1977, 14(3): 425-436.
Properties of 5-TRANS U-46619
storage temp. | Store at -20°C |
solubility | ≤100mg/ml in ethanol;100mg/ml in DMSO;100mg/ml in dimethyl formamide;2mg/ml in PBS(pH7.2) |
form | solution in acetate. |
Safety information for 5-TRANS U-46619
Computed Descriptors for 5-TRANS U-46619
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium 3-Bromopyrazole (3aR,4R,5R,6aS)-hexahydro-5-Triethyl silyloxy-4-((E)-3-oxo-5-phenylpent-1- enyl)cyclopenta[b]furan-2-one. 1-Chlorocarbonyl-4-piperidinopiperidine 1-Bromo-4-phenyl-2-Butanone 4-Amino-2-fluoro-N-methylbenzamide 1,1'-Carbonyldiimidazole SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTIONRelated products of tetrahydrofuran
You may like
-
Dimethyl [2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate 99%View Details
54094-19-8 -
85-81-4 99%View Details
85-81-4 -
Cyclopentane carboxxylic acid 3400-45-1 99%View Details
3400-45-1 -
208111-98-2 (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten- 1-yl]-2H-cyclopenta[b]furan-2-one 99%View Details
208111-98-2 -
2033-24-1 99%View Details
2033-24-1 -
Meldrums acid 2033-24-1 99%View Details
2033-24-1 -
Cyaclopentane carboxylic acid 99%View Details
3400-45-1 -
2-Aminopyridine 504-29-0 99%View Details
504-29-0